Psychotropics |
Dose |
Comments |
Haloperidol |
– Initial dose: 0.25 mg in frail older patients (0.5-1 mg in robust or younger patients) – May be given PO, SC, IM, or IV – May be given every 4 h, not exceeding 2 mg in a 24-h period in older patients |
– FDA “black-box warning” for risk of arrhythmia and death when dose is >10 mg in a 24-h period in patients of all ages – Parenteral route available – May cause QT prolongation |
Risperidone |
– Initial dose: 0.25 mg in frail older adults (0.5 mg in robust or younger patients) – May be given bid, not exceeding 2 mg in a 24-h period in older patients |
– PO only – May cause QT prolongation
|
Quetiapine |
– Initial dose: 6.25-12.5 mg in frail older patients (25 mg for robust or younger patients) – May be given bid |
– PO only – Increased risk of sedation – May cause QT prolongation – Least likely to cause extrapyramidal adverse effects. Can be considered in patients with Parkinson disease |
Lorazepam or other benzodiazepine |
– For lorazepam, initial dose 0.5 mg – May be given PO, SC, IM, or IV |
– Use for alcohol withdrawal – Consider in patients with Parkinson disease |
bid, 2 times a day; FDA, US Food and Drug Administration; IM, intramuscular; IV, intravenous; PO, oral; SC, subcutaneous. |